qz
Pfizer is teaming up with a Chinese biotech on a $10.5 billion cancer drug deal

The U.S. pharma giant will pay $650 million upfront to China's Innovent Biologics to co-develop 12 early-stage oncology programs [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Red teaming LLMs exposes a harsh truth about the AI security arms race

Unrelenting, persistent attacks on frontier models make them fail, with the patterns of failure varying by model and developer. Red teaming shows that it’s not the sophisticated, complex attacks tha [...]

Match Score: 109.73

Destination
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

Match Score: 90.76

Destination
FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Match Score: 82.65

venturebeat
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science a [...]

Match Score: 75.57

thenextweb
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]

Match Score: 70.75

Destination
Tony Hogben, Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS) – Interview Series

Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how [...]

Match Score: 69.16

qz
Pfizer's experimental lung cancer drug fails to extend survival in late-stage trial

The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study [...]

Match Score: 48.98

Destination
Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices

Pfizer's CEO says nothing concrete has happened in the 30 days since Trump's executive order [...]

Match Score: 41.45

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 40.66